{"data":{"id":1275,"citation":"Horikawa M, Kato Y, Tyson CA, Sugiyama Y.: The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet, Volume 17 (1), 2002","title":"The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.","doi":"10.2133\/dmpk.17.23","doi_url":"https:\/\/doi.org\/10.2133\/dmpk.17.23","pmid":"15618649","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/15618649\/","year":2002,"journal":"Drug Metab Pharmacokinet","volume":"17","issue":"1","page":"23-33","authors":[{"first_name":"Horikawa M","last_name":null,"full_name":null},{"first_name":"Kato Y","last_name":null,"full_name":null},{"first_name":"Sugiyama Y.","last_name":null,"full_name":null},{"first_name":"Tyson CA","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/1275","landing_page":"https:\/\/molmedb.upol.cz\/publication\/1275","created_at":"2021-01-20T08:55:45.000000Z","updated_at":null}}